Publications (12) Publications in which a researcher has participated View referenced research data.

filter_list Internal Medicine

2025

  1. Resectable Non-Small Cell Lung Cancer Heterogeneity and Recurrence Assessed by Tissue Next-Generation Sequencing Genotyping and Circulating Tumor Cell EZH2 Characterization

    Archivos de Bronconeumologia, Vol. 61, Núm. 3, pp. 156-165

2024

  1. DNA G-quadruplexes in the genome of Trypanosoma cruzi as potential therapeutic targets for Chagas disease: Dithienylethene ligands as effective antiparasitic agents

    European Journal of Medicinal Chemistry, Vol. 276

  2. EZH2 represses mesenchymal genes and upholds the epithelial state of breast carcinoma cells

    Cell Death and Disease, Vol. 15, Núm. 8

2023

  1. Epigenetic marks associated with gestational diabetes mellitus across two time points during pregnancy

    Clinical Epigenetics, Vol. 15, Núm. 1

  2. Epigenome wide association study in peripheral blood of pregnant women identifies potential metabolic pathways related to gestational diabetes

    Epigenetics, Vol. 18, Núm. 1

2022

  1. EZH2 endorses cell plasticity to non-small cell lung cancer cells facilitating mesenchymal to epithelial transition and tumour colonization

    Oncogene, Vol. 41, Núm. 28, pp. 3611-3624

2020

  1. Association of ABCB1 and VEGFA gene polymorphisms with breast cancer susceptibility and prognosis

    Pathology Research and Practice, Vol. 216, Núm. 4

2018

  1. Activating transcription factor 4 modulates TGFb-induced aggressiveness in triple-negative breast cancer via SMad2/3/4 and mTORC2 signaling

    Clinical Cancer Research, Vol. 24, Núm. 22, pp. 5697-5709

  2. Stratification of Systemic Lupus Erythematosus Patients Into Three Groups of Disease Activity Progression According to Longitudinal Gene Expression

    Arthritis and Rheumatology, Vol. 70, Núm. 12, pp. 2025-2035

2016

  1. Prognostic factor analysis of circulating tumor cells in peripheral blood of patients with peritoneal carcinomatosis of colon cancer origin treated with cytoreductive surgery plus an intraoperative hyperthermic intraperitoneal chemotherapy procedure (CRS + HIPEC)

    Surgery (United States), Vol. 159, Núm. 3, pp. 728-735

2015

  1. Influence of the HER2 Ile655Val polymorphism on trastuzumab-induced cardiotoxicity in HER2-positive breast cancer patients: A meta-analysis

    Pharmacogenetics and Genomics, Vol. 25, Núm. 8, pp. 388-393

  2. Prognostic role of genetic biomarkers in clinical progression of prostate cancer

    Experimental and Molecular Medicine, Vol. 47, Núm. 8